This Article Full Text Full Text (PDF) All Versions of this Article: 93/4/1298    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Steiner, A. Z. Articles by Stanczyk, F. Z. PubMed PubMed Citation Articles by Steiner, A. Z. Articles by Stanczyk, F. Z. Related Collections Female Endocrinology

3-Hydroxysteroid Dehydrogenase Type III Deficiency: A Novel Mechanism for Hirsutism

Department of Obstetrics and Gynecology (A.Z.S.), University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599; and Departments of Obstetrics and Gynecology (L.C., R.J.P., F.Z.S.) and Medicine (Q.J., M.O., A.S.), University of Southern California Keck School of Medicine, Los Angeles, California 90033

Address all correspondence and requests for reprints to: Anne Z. Steiner, M.D., M.P.H., University of North Carolina, Campus Box 7570, Old Clinic Building, Chapel Hill, North Carolina 27599. E-mail: asteiner{at}med.unc.edu.

Context: Dihydrotestosterone (DHT), the primary active androgen in peripheral target tissues, is metabolized by 3-hydroxysteroid dehydrogenase type III (3-HSD), encoded by the AKR1C2 gene, forming 5-androstane-3,17β-diol (3-diol). 3-HSD may play a role in the pathogenesis of hirsutism.

Objectives: Our objective was to evaluate the role of 3-HSD in hirsutism by comparing 1) tissue levels of active androgens, 2) relative gene expression of AKR1C2, and 3) activity of 3-HSD in genital skin from normal and hirsute women.

Design: Genital skin was obtained from normal and hirsute women. After homogenization, testosterone (T) and DHT levels were quantified by conventional RIA. From isolated RNA, relative expression of AKR1C2 was determined by real-time PCR. In addition, minced genital skin was incubated with [³H]DHT, and the product, [³H]3-diol, was quantified by radio-HPLC.

Setting: The study took place at an inner-city hospital.

Patients: Patients included women undergoing posterior colporrhaphy.

Main Outcome Measures: We assessed 1) tissue levels of T, DHT, and 3-diol; 2) relative expression of AKR1C2; and 3) conversion ratio of [³H]3-diol to [³H]DHT.

Results: In genital skin, tissue DHT and T concentrations in hirsute women were 1.90-fold and 1.84-fold higher than in normal women (P =0 .002 and 0.03), and relative expression of AKR1C2 mRNA was reduced approximately 7-fold (P = 0.04). Genital skin from hirsute women showed less metabolism of [³H]DHT to [³H]3-diol (conversion ratio, 0.24 ± 0.19 vs. 0.85 ± 0.55, P = 0.01).

Conclusions: In genital skin of hirsute women, reduced AKR1C2 gene expression and 3-HSD activity results in decreased DHT metabolism and elevated tissue levels of DHT. Diminished DHT metabolism may play an important role in the pathogenesis of hirsutism.